Haroon Faraz, MD
Interventional Cardiology · Teaneck, NJNPI 1629250535
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (30.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Abiomed at 59.2% of the total. Among interventional cardiology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 577 payments — averaging $170.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$58K
- Medtronic$15K
- Shockwave Medical, Inc$7K
- Spectrawave, Inc$5K
- Inari Medical, Inc.$2K
- Penumbra, Inc.$2K
- plus $8K from 29 others
Across 44 payments — averaging $3933.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$143K
- Abiomed$30K
- ZOLL Circulation Inc$220
What the payments were for
- Consulting fees$12,02512%
- Speaking & faculty fees$30,45031%
- Travel & lodging$29,53230%
- Food & beverage$26,42327%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 253 | $58,232 |
| Medtronic(2 entities) | 141 | $15,154 |
| Shockwave Medical, Inc | 14 | $6,715 |
| Spectrawave, Inc | 16 | $5,457 |
| Inari Medical, Inc. | 8 | $2,435 |
| Penumbra, Inc. | 8 | $2,124 |
| Cathworks, Inc. | 2 | $1,199 |
| Abbott | 14 | $1,044 |
| Amgen | 26 | $771 |
| Boston Scientific | 9 | $607 |
| ZOLL Circulation Inc | 4 | $596 |
| Edwards Lifesciences | 4 | $593 |
| Siemens Medical Solutions USA, Inc. | 4 | $423 |
| Cardiovascular Systems Inc. | 8 | $369 |
| Cvrx, Inc. | 2 | $354 |
| Novartis | 19 | $335 |
| Recor Medical Inc | 2 | $274 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $236 |
| W. L. Gore & Associates, Inc. | 1 | $175 |
| Teleflex LLC | 2 | $169 |
| Reflow Medical Inc | 2 | $158 |
| Saranas, Inc. | 2 | $144 |
| Cardiva Medical, Inc. | 1 | $136 |
| Merck | 9 | $134 |
| Corcept Therapeutics | 1 | $122 |
| Terumo Medical Corporation | 1 | $116 |
| Irhythm Technologies, Inc. | 3 | $77 |
| Amarin Pharma, Inc. | 5 | $69 |
| Pfizer | 4 | $56 |
| AstraZeneca | 4 | $52 |
| Atricure, Inc. | 1 | $35 |
| Heartflow, Inc. | 1 | $24 |
| La Jolla Pharmaceutical Company | 1 | $18 |
| Angiodynamics, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$47,061
- RESOLUTE ONYX$6,679
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$6,462
- HyperVue Imaging System$5,124
- Starlight Imaging Catheter$5,124
- X1-FFR$3,727
- FLOWTRIEVER CATHETER, S$2,344
- CT THROMBECTOMY SYSTEM KIT$2,344
- CoreValve Evolut$2,078
- Indigo System$1,833
- ONYX FRONTIER$1,511
- FFRangio$1,199
- Viva$559
- SYMPLICITY G3$452
- TherOx DS2 Console$450
- Catheter$450
- Downstream Cartridge$450
- Repatha$368
- Barostim Neo System$354
- Paradise Ultrasound Renal Denervation System$274
How this compares
$98,430 in reported general payments places this provider in the 90th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 78 | $85,012 |
| EntrestoSacubitril/Valsartan | 38 | $46,368 |
| Repatha SureclickEvolocumab | 49 | $38,616 |
| BrilintaTicagrelor | 24 | $21,717 |
| JardianceEmpagliflozin | 17 | $20,616 |
| Repatha PushtronexEvolocumab | 30 | $19,573 |
| VascepaIcosapent Ethyl | 15 | $5,983 |
| Ranolazine ErRanolazine | 54 | $5,842 |
| Ezetimibe | 99 | $3,341 |
| ClopidogrelClopidogrel Bisulfate | 190 | $2,450 |
| Metoprolol Succinate | 163 | $2,308 |
| Atorvastatin Calcium | 215 | $2,037 |
| Valsartan | 44 | $1,618 |
| Losartan Potassium | 97 | $1,001 |
| Carvedilol | 88 | $942 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $56 | $85,01278 claims |
| NovartisEntresto | $335 | $46,36838 claims |
| AstraZenecaBrilinta | $52 | $21,71724 claims |
| Boehringer IngelheimJardiance | $12 | $20,61617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 166 interventional cardiology providers in New Jersey.
Other interventional cardiology in Teaneck
- Ankitkumar PatelGlen Ridge$408K
- Ziad AbbudOcean$360K
- Ramin HastingsHasbrouck Heights$295K
- Michael LimHackensack$215K
- Darshan GodkarCedar Knolls$194K
- Ryan KapleHackensack$178K
- Matthew SayboltEatontown$175K
- Daniel KissEatontown$172K
- Kintur SanghviBordentown$139K
- Dimitrios KarmpaliotisMorristown$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.